Reset filter
Keywords
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

373 Search results.
Relevance Rating New first Old first

Eligibility Rheumatoid Arthritis NCT00000401

- 1/15/16 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Oral Collagen for Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00000401

Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects NCT01440426 - Eligibility Coverage of Multiple Gingival Recession Defects NCT01440426

- 5/18/15 - 1 form, 2 itemgroups, 3 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01440426 NCT01440426

Eligibility Knee Osteoarthritis (OA) NCT00536302

- 3/6/17 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Placebo-Controlled Study of Collagen Hydrolysate in Subjects With Knee Osteoarthritis (OA); ODM derived from: https://clinicaltrials.gov/show/NCT00536302

Eligibility Soft Tissue Volume Augmentation DRKS00003586 NCT02356770 DRKS00003586 - Eligibility Soft Tissue Volume Augmentation NCT02356770 DRKS00003586

- 7/4/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Responsible Party: Geistlich Pharma AG ClinicalTrials.gov Identifier: NCT02356770 History of Changes Other Study ID Numbers: 10860 DRKS00003586 ( Registry Identifier: Deutsches Register Klinischer Studien ) CIV-11-12-003323 ( Other Identifier: EUDAMED ) Study First Received: December 18, 2014 Last Updated: February 2, 2015 A Clinical Study to Investigate Collagen Matrix 10808 for Soft Tissue Volume Augmentation Around Single Implants ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02356770

Eligibility Rheumatoid Arthritis NCT00650078

- 9/20/21 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00650078

Eligibility Rheumatoid Arthritis NCT00162201

- 9/20/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00162201

Eligibility Systemic-Onset Juvenile Idiopathic Arthritis NCT00339157

- 9/20/21 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS; ODM derived from: https://clinicaltrials.gov/show/NCT00339157

Eligibility Rheumatoid Arthritis NCT01745055

- 9/20/21 - 1 form, 2 itemgroups, 6 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Co-Administration Of Methotrexate And CP-690,550; ODM derived from: https://clinicaltrials.gov/show/NCT01745055

Eligibility Osteo Arthritis of the Knees NCT02178137

- 8/18/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Interventions on the Progression of Knee Osteoarthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02178137

Eligibility Psoriatic Arthritis NCT01212757

- 7/17/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01212757

Eligibility Rheumatoid Arthritis NCT01166620

- 6/23/21 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics; ODM derived from: https://clinicaltrials.gov/show/NCT01166620

Eligibility Psoriatic Arthritis in Psoriasis NCT01316224

- 6/15/21 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01316224

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial